Last reviewed · How we verify
Intrathecal dexmedetomidine
At a glance
| Generic name | Intrathecal dexmedetomidine |
|---|---|
| Also known as | saline intrathecally |
| Sponsor | Tanta University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery (PHASE2)
- Comparing Doses of Intrathecal Dexmedetomidine (PHASE4)
- Intrathecal Morphine for Recovery and Outcomes After VATS (NA)
- Comparison Between Intrathecal Magnesium Sulphate & Dexmedetomidine in DHS (PHASE3)
- Comparative Dose-Response of Intrathecal Dexmedetomidine for Post-Spinal Shivering (PHASE3)
- Intrathecal Dexmedetomidine vs Epinephrine (PHASE4)
- Comparative Analysis of Intraoperative Effect Dexmedetomidine and Fentanyl as an Adjuvant to Heavy Bupivacaine in Spinal Anaesthesia in Lower Limb Orthopedic Surgeries to Evaluate the Hemodynamic Stability and Onset and Duration of Motor Block of Using Intrathecal Dexmedetomidine and Fentanyl (PHASE4)
- Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |